2020年，作为上交所科创板改革的第一批种子，国盾量子（688027.SH）的IPO悄然创下一个纪录—— 它不仅成为中国，乃至全球首家以量子科技业务为核心的上市公司，也是资本市场上罕见的将推动前沿 研究作为重要方向的上市公司。 此种在"无人区"中的坚守，在外人看来是难以复刻的奇迹，但在唐世彪看来却是"九死一生"的冒险。 唐世彪是国盾量子的创始成员，现任公司董事、副总裁和副总工程师。同时，他还身兼安徽省量子信息 工程技术研究中心主任等职责。 集"产学研"多种标签于一身的身份，让唐世彪一直处在前沿科学与技术应用的前沿。 如今，"十五五"规划建议将量子技术列为发展前沿技术的核心领域。而作为规划的见证者、推动者，唐 世彪对量子科技发展在国际形势日趋复杂，AI应用不断深化的当下，有着独到的看法。 从技术到产业化 "我最开始是做了两年博士后，这个身份其实有些可攻可守的意味。"唐世彪回忆起自己的创业经历时表 示："当时并未预料到，会有那么多'生死存亡'的时刻。" 虽然说是"兼职"，唐世彪仍然全身心投入在创业之中，专注于解决量子通信的商业化技术难题。 "光是从0到1的材料费、设备费就是一笔巨大的开支。在那个阶段，社会资本对量 ...

证券代码：688027 证券简称：国盾量子 公告编号：2026-004 科大国盾量子技术股份有限公司 关于日常关联交易的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性依法承担法律责任。 重要内容提示： ●科大国盾量子技术股份有限公司（以下简称"国盾量子"或"公司"）拟与国科量子通信网络有限公司 （以下简称"国科量网"）签订1份销售服务合同，主要为京沪干线量子设备提供维保服务，预计金额为 180.00万元。 ●包含上述与国科量网交易，自此往前追溯12个月，公司与关联方签订的销售服务合同金额合计为 465.54万元（剔除公司已对外披露的关联交易金额）。 ●本次交易未构成重大资产重组。 ●本次交易实施不存在重大法律障碍。 ●本次日常关联交易系公司日常经营活动，不会影响公司的经营独立性，公司不会因本次日常关联交易 而对关联方形成重大依赖。 ●本次日常关联交易事项已经公司第四届董事会独立董事第十七次专门会议、第四届董事会第二十一次 会议审议通过，该事项无需提交公司股东会审议。 一、关联交易概述 公司拟与国科量网签订1份销售服务合同，主要为京沪干 ...

Group 1: Earnings Forecasts - Huabang Health expects a net profit of 660 million to 730 million yuan for 2025, recovering from a loss of 299 million yuan in the previous year, driven by improvements in its agricultural chemical materials sector and steady growth in its pharmaceutical and tourism segments [2] - Kangda New Materials anticipates a net profit of 125 million to 135 million yuan for 2025, compared to a loss of 246 million yuan last year, primarily due to significant sales growth in adhesive and specialty resin products, particularly in the wind power sector [2] - Longxin Technology forecasts a net profit of 100 million to 150 million yuan for 2025, recovering from a loss of 250 million yuan, with improvements in its energy digitalization business and reduced losses in its new energy sector [3] - Hualu Bio expects a net profit of 100 million to 130 million yuan for 2025, recovering from a loss of 47.57 million yuan, attributed to increases in both sales price and volume [3] - Jiuxi Software predicts a net profit of 40 million to 60 million yuan for 2025, recovering from a loss of 156 million yuan, supported by AI technology enhancements and market expansion strategies [3] Group 2: Major Corporate Developments - Liou Co. has completed its stock suspension review and will resume trading on January 21, 2026, confirming that its business operations remain normal and no significant undisclosed matters exist [4] - Hikvision reported total revenue of 92.518 billion yuan for 2025, a slight increase of 0.02%, with a net profit of 14.188 billion yuan, up 18.46%, driven by strategic adjustments and improved cash flow management [6] - JianTou Energy expects a net profit of approximately 1.877 billion yuan for 2025, a significant increase of about 253.38% from the previous year, due to optimized coal resource allocation and cost management [6] Group 3: Investment and Mergers - Aibo Medical plans to acquire at least 51% of Demai Medical to gain control, aiming to leverage its R&D advantages in the sports health sector [19] - Yifan Transmission intends to purchase 87.07% of Beijing Helishi Motor Technology Co., which will become a subsidiary upon successful completion of the transaction [16] - Guangdong Hongtu plans to invest up to 95 million yuan to establish a subsidiary in Thailand for automotive parts production and sales [20] Group 4: Stock Performance and Changes - Huicheng Environmental's major shareholder plans to increase their stake in the company by investing between 25 million and 50 million yuan within six months [22] - Liou Co. will resume trading after completing its stock suspension review, indicating stability in its operations [24] - Kailong High-Tech and Debang Co. have been suspended from trading, indicating potential issues or developments requiring further clarification [25]

Group 1 - Liou Co., Ltd. announced that its stock price fluctuations have been investigated, confirming normal operations and no undisclosed significant information [1] - Tongfu Microelectronics expects a net profit of 1.1 billion to 1.35 billion yuan for 2025, representing a year-on-year growth of 62.34% to 99.24% [17][18] Group 2 - Zhongtung High-tech reported an increase of 91,700 tons in tungsten metal resources, which will not directly impact its current operations or financial situation [2] - Aibo Medical plans to acquire at least 51% of Demai Medical to gain control, aiming to cultivate new profit growth points in the sports medicine sector [2] Group 3 - Zhaojin Gold confirmed normal operations and no undisclosed significant matters after its stock price experienced abnormal fluctuations [3] - Riying Electronics stated that it has no revenue from humanoid robot-related businesses and emphasized the need for rational investment decisions [4] Group 4 - Yifan Transmission intends to purchase 87.07% of Beijing Helishi Electric Technology Co., Ltd., which is expected to constitute a major asset restructuring [5] - China Merchants Industry plans to build four 3000TEU traditional fuel container ships with a total investment of no more than 1.324 billion yuan [6] Group 5 - Jiangtian Chemical plans to invest 49.8 million yuan in a project to produce 60,000 tons of acrylic acid annually [7] - *ST Xinyan has received approval to lift its delisting risk warning after completing its restructuring plan [7] Group 6 - Kangxin New Materials intends to acquire 51% of Wuxi Yubang Semiconductor for 392 million yuan, marking its expansion into the semiconductor field [8] - Guoshun Quantum signed a technology implementation license contract with the University of Science and Technology of China [8] Group 7 - Zhenyu Technology reported a significant increase in orders from the robotics sector for Q4 2025, although these orders represent a small portion of its overall revenue [9] - Yongxing Materials announced that its lithium extraction project has reached full production capacity [9] Group 8 - Nanjing Julong plans to invest 110 million yuan in a production line for modified plastics with an annual capacity of 60,000 tons [9] - Guodian Nanzi signed a strategic cooperation agreement with Huawei to establish an AI technology innovation center [10][11] Group 9 - He Sheng New Materials plans to sell idle factory assets for no less than 80 million yuan [13] - He Sheng New Materials expects a net profit increase of 55% to 75% for 2025, driven by improved supply chain management [14] Group 10 - Kangda New Materials forecasts a net profit of 125 million to 135 million yuan for 2025, marking a turnaround from a loss in the previous year [15] - Yanjing Beer anticipates a net profit increase of 50% to 65% for 2025, supported by its large product strategy [16] Group 11 - Jinfang Energy expects a net profit of 109 million to 143 million yuan for 2025, reflecting a year-on-year growth of 123.97% to 193.7% [19] - Yandong Microelectronics predicts a net loss of 340 million to 425 million yuan for 2025 due to market changes and increased R&D costs [20] Group 12 - Taishan Petroleum forecasts a net profit increase of 30.88% to 66.11% for 2025, benefiting from reduced expenses [21] - Huayuan Holdings expects a net profit increase of 50.98% to 66.82% for 2025, driven by lower raw material prices [22] Group 13 - Huajin Co. anticipates a net loss of 1.6 billion to 1.9 billion yuan for 2025, although the loss is expected to be less than the previous year [23] - Zhongyuan Neipei expects a net profit increase of 80.47% to 109.9% for 2025, supported by steady growth in core business [24] Group 14 - Dongfang Tower expects a net profit of 1.08 billion to 1.27 billion yuan for 2025, reflecting a year-on-year growth of 91.4% to 125.07% [34] - Dali Long anticipates a net profit increase of 51.88% to 86.27% for 2025, driven by market expansion and operational efficiency [35] Group 15 - Hikvision reported a net profit increase of 18.46% for 2025, with total revenue reaching 925.18 billion yuan [44] - Zhongfu Industrial expects a net profit increase of 120.27% to 141.59% for 2025, primarily due to lower costs in the electrolytic aluminum business [45]

每经AI快讯，国盾量子1月20日晚间发布公告称，公司第四届第二十一次董事会会议于2026年1月20日 在公司会议室召开。会议审议了《关于公司日常关联交易的议案》等文件。 （记者 王晓波） 每经头条（nbdtoutiao）——"一周干完一年的活"，一款AI编程工具让硅谷程序员集体"上瘾"！科技公 司CEO：一辈子钻研的技能被它一次性解决，让人兴奋又恐惧 ...

Core Viewpoint - The company GuoDun Quantum (688027) plans to sign licensing agreements with the University of Science and Technology of China (USTC) for several patents and proprietary technologies, indicating a strategic move to enhance its technological capabilities and product offerings [1] Group 1: Licensing Agreements - The company intends to sign a patent and proprietary technology licensing contract with USTC, involving 4 patents, 3 software copyrights, and 2 proprietary technologies [1] - The ownership of the technological achievements will be jointly held by USTC and another party [1] - The company will pay an entrance fee and sales share as per the contract terms [1] Group 2: Additional Agreements - The company plans to sign another patent and proprietary technology licensing contract with the other owner of the technological achievements, with terms consistent with those of the agreement with USTC [1]

格隆汇1月20日丨国盾量子(688027.SH)公布，公司非独立董事蒋成先生因工作调整原因申请辞去公司董 事职务，辞职后不再担任公司任何职务，其原定任期至第四届董事会换届选举完成之日止。 近日，公司收到控股股东中电信量子信息科技集团有限公司来函推荐，并经董事会提名委员会进行资格 审查，公司董事会拟提名张文强先生、甘雨先生为公司第四届董事会非独立董事候选人，任期自股东会 审议通过之日起至第四届董事会任期届满之日止。 ...

国元证券股份有限公司 公司类型:有限责任公司(国有控股) 关于科大国盾量子技术股份有限公司 日常关联交易事项的核查意见 国元证券股份有限公司（以下简称"国元证券"或"保荐机构"）作为科大 国盾量子技术股份有限公司（以下简称"公司"或"国盾量子"）2024年度向特 定对象发行 A 股股票的保荐机构,根据《上市公司证券发行注册管理办法》《证 券发行上市保荐业务管理办法》《上海证券交易所科创板股票上市规则》《上海证 券交易所科创板上市公司自律监管指引第 1 号――规范运作》等有关法律法规和 规范性文件的要求,对国盾量子拟发生的日常关联交易事项进行了专项核查,具 体核查情况如下: 一、关联交易概述 根据公司第四届董事会第二十一次会议审议通过,公司(含子公司)拟与国 科量子通信网络有限公司（以下简称"国科量网"）签订 1 份销售服务合同，主 要为京沪于线量子设备提供维保服务，预计金额为 180 万元。 包含本次关联交易，过去 12 个月内，公司与同一关联人，或与不同关联人 进行同一类别下的关联交易合同金额均未达到公司最近一期经审计总资产或市 值 1%且不超过 3,000 万元。本次关联交易议案无需提交公司股东会审议。本 ...

近日，公司收到控股股东中电信量子信息科技集团有限公司来函推荐，并经董事会提名委员会进行资格 审查，公司董事会拟提名张文强先生、甘雨先生为公司第四届董事会非独立董事候选人，任期自股东会 审议通过之日起至第四届董事会任期届满之日止。 格隆汇1月20日丨国盾量子(688027.SH)公布，公司非独立董事蒋成先生因工作调整原因申请辞去公司董 事职务，辞职后不再担任公司任何职务，其原定任期至第四届董事会换届选举完成之日止。 ...

Core Viewpoint - The company, Guodun Quantum (688027.SH), plans to sign licensing agreements with the University of Science and Technology of China (USTC) for several patents and software copyrights, indicating a strategic move to enhance its technological capabilities and business operations [1] Group 1: Licensing Agreements - The company intends to sign one patent/technology licensing contract and one software copyright/technology licensing contract with USTC, involving a total of 4 patents, 3 software copyrights, and 2 proprietary technologies [1] - The ownership of the technological achievements will be jointly held by USTC and another party [1] - The company will pay an entry fee and sales share as stipulated in the contract [1] Group 2: Additional Agreements - The company plans to sign similar licensing agreements with the other owner of the technological achievements, with terms including licensing method, duration, and fees consistent with those agreed upon with USTC [1]